Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • anjama
    Member
    • Mar 2016
    • 15

    #1

    PstI methylation sensitivity

    So my lab is in the process of understanding and implementing a protocol for several species. One point of confusion we are trying to figure out is whether or not the PstI restriction enzyme is methylation sensitive. The reason this is a concern is that the protocol calls for methylation sensitive enzymes, and people involved in developing the protocol use PstI as a methylation-sensitive enzyme for a variety of species ranging from plants to mammals. However, the product pages for Fisher and NEB both list PstI as not sensitive for dam, dcm, and CpG sites. The only indication I can see on manufacturer sites that it is sensitive is a reference chart on Promega's website that lists it as sensitive to CpNpG methylation sites.

    Just taking a quick look through primary literature, many papers seem to refer to PstI as methylation sensitive, but I've also seen some that refer to it as non-sensitive. From what I gather, CpNpG sites are predominately a plant thing, whereas the mammal genome consists of primarily CpG sites (I think I saw the number 97% somewhere), which seems like it explains the discrepancy between different papers. Is this right? Is it correct to consider PstI non-methylation sensitive for mammals, but methylation sensitive for plants? Or am I missing something? Thanks
  • SNPsaurus
    Registered Vendor
    • May 2013
    • 525

    #2
    For RAD-Seq work in plants, PstI acts as if it is methylation-sensitive, as you'll get a number of cut sites sequenced that is consistent with the genome being several hundred megabases in size, regardless of the actual genome size (plants have a small amount of non-repetitive DNA with most of the variation in size coming from methylated repeats).

    PstI cut sites tend to scale with genome size in mammals, so it acts insensitive there. These are not direct tests of sensitivity, of course, but it is consistent with the enzyme companies sites. So you are correct, I'd say!
    Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Working...